Who owns RHYTHM PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RYTM from SEC Form 13F filings across 334 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 334 institutions disclosed 79.0M shares of RHYTHM PHARMACEUTICALS, INC. worth $7.52B — about 114.5% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
334
13F holders
$7.52B
value, 2026 filers
114.5%
of shares outstanding (79.0M sh)
60
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RYTM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 6.7M | $634.8M | 6.4% | 9.7% | 0.0% |
| 2 | BlackRock, Inc. | 6.0M | $568.9M | 0.0% | 8.7% | -2.9% |
| 3 | BAKER BROS. ADVISORS LP | 5.6M | $533.6M | 2.5% | 8.1% | 0.0% |
| 4 | JPMORGAN CHASE & CO | 3.6M | $340.8M | 0.0% | 5.2% | +34.1% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.1M | $299.8M | 0.0% | 4.6% | +0.4% |
| 6 | PRIMECAP MANAGEMENT CO/CA/ | 3.1M | $291.8M | 0.2% | 4.4% | -3.3% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $286.2M | 0.0% | 4.4% | 0.0% |
| 8 | STATE STREET CORP | 2.6M | $251.2M | 0.0% | 3.8% | +2.5% |
| 9 | PERCEPTIVE ADVISORS LLC | 2.5M | $241.1M | 4.2% | 3.7% | -2.1% |
| 10 | WESTFIELD CAPITAL MANAGEMENT CO LP | 2.5M | $236.2M | 0.8% | 3.6% | +12.3% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.3M | $222.3M | 0.0% | 3.4% | -9.0% |
| 12 | GOLDMAN SACHS GROUP INC | 2.1M | $201.6M | 0.0% | 3.1% | -0.4% |
| 13 | FEDERATED HERMES, INC. | 1.9M | $179.0M | 0.3% | 2.7% | +5.3% |
| 14 | Polar Capital Holdings Plc | 1.7M | $158.1M | 0.4% | 2.4% | -0.2% |
| 15 | Capital Research Global Investors | 1.6M | $151.8M | 0.0% | 2.3% | +4.1% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $147.6M | 0.0% | 2.2% | +1.1% |
| 17 | Checkpoint Capital L.P. | 1.2M | $115.8M | 26.2% | 1.8% | +2.6% |
| 18 | Orbis Allan Gray LtdNEW | 1.2M | $113.9M | 0.4% | 1.7% | new |
| 19 | Siren, L.L.C. | 1.1M | $103.4M | 2.4% | 1.6% | -4.4% |
| 20 | Pictet Asset Management Holding SA | 976,487 | $93.0M | 0.1% | 1.4% | +2.0% |
| 21 | FMR LLC | 914,285 | $87.1M | 0.0% | 1.3% | -10.9% |
| 22 | MORGAN STANLEY | 913,005 | $86.9M | 0.0% | 1.3% | -17.9% |
| 23 | Janus Henderson Group Ltd.NEW | 858,873 | $81.8M | 0.0% | 1.2% | new |
| 24 | ALLIANCEBERNSTEIN L.P. | 839,597 | $79.9M | 0.0% | 1.2% | -6.2% |
| 25 | Clearbridge Investments, LLC | 795,077 | $75.7M | 0.1% | 1.2% | +14.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.